Introduction
Throughout the history of the world, the ones who had confronted the bitterest face of poverty and war had always been the women. As known poverty and war affects human health either directly or indirectly, the effects of this condition on health and status of women in the society should not be ignored. This study intends to cast light on the effects of war and poverty on the reproductive health of women. For this purpose, the face of war affecting the women, the problem of immigration, inequalities in distribution of income based on gender and the effects of all these on the reproductive health of women will be addressed.
War and Women's Health
Famine, synonymous with war and poverty, is clearer for women; war means deep disadvantages such as full destruction, loss of future and uncertainty for women. Wars are conflicts that destroy families, societies and cultures that negatively affect the health of community and cause violation of human rights. According to the data of World Health Organization (WHO) and World Bank, in 2002 wars had been among the first ten reasons which killed the most and caused disabilities. Civil losses are at the rate of 90% within all losses (1). War has many negative effects on human health. One of these is its effect of shortening the average human life. According to the data of WHO, the average human life is 68.1 years for males and 72.7 years for females. It is being thought that severe military conflicts in Africa shorten the expected lifetime for more than 2 years. In general, WHO had calculated that 269 thousand people had died in 1999 due to the effect of wars and that loss of 8.44 million healthy years of life had occurred (2, 3) . Wars negatively affect the provision of health services. Health institutions such as hospitals, laboratories and health centers are direct targets of war. Moreover, the wars cause the migration of qualified health employees, and thus the health services hitches. Assessments made indicate that the effect of destruction in the infrastructure of health continues for 5-10 years even after the finalization of conflicts (3) . Due to resource requirements in the restructuring investments after war, the share allocated to health has decreased (1).
Mortalities and Morbidities
The ones who are most affected from wars are women and children. While deaths depending on direct violence affect the male population, the indirect deaths kill children, women and elders more. In Iraq between 1990-1994, infant deaths had shown this reality in its more bare form with an increase of 600% (4). The war taking five years increases the child deaths under age of 5 by 13%. Also 47% of all the refugees in the world and 50% of asylum seekers and displaced people are women and girls and 44% refugees and asylum seekers are children under the age of 18 (5) . As the result of wars and armed conflicts, women are
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Due to the pressure of the mass, the ovaries could not be checked. Free fluid was observed in the abdominal cavity. Muscle tissue and bone of hip region were normal and there was no sign of lymphadenopathy. Furthermore, the results of endometrial biopsy, performed on the patient in October 2015, indicated no presence of malignancy. At the same time, the report of Pap smear indicated chronic cervicitis, and in CBC diff, Hb was 11. Therefore, based on these findings and vaginal bleeding from which the patient was suffering, a surgery was performed on the patient in January 2016. During surgery, an enlarged uterus, like the size of 20-week pregnancy, was observed, while there was a connection of dense adhesions of the omentum to mass and anterior abdominal wall. The mass arose from the uterine fundus originated from peritoneum and lobulated omentum (Figure 1 ). The samples from mass along with solid components, cystic and hemorrhage were then sent to the cytology laboratory of the hospital. Uterus, Fallopian tubes and ovaries were removed during the surgery, and the patient received 3 units of packed red blood cells (RBC).
Macroscopic Features of Mass
The dissection of enlarged uterus revealed an oval-shaped mass with the size of 27×20×15 cm and diameter of 11 cm inside the uterus cavity that had spread throughout the cervix. The cross-section of mass showed a gray-white, fleshy, and lobulated cut surface that contained foci of hemorrhage.
Microscopic Features of Mass
Evaluation of the issue sections showed spindle cells containing hyperchromatic nuclei and eosinophilic cytoplasm. The taken images indicated mitotic (M) phase containing atypical mitosis (high-power fields [HPF] >10/10) and foci of necrosis. The total findings suggested LMS with cervix involvement. Peritoneal washings (PW) and cytologic analysis indicated no malignant cells.
There was no post-operative complication. The patient was discharged 7 days after the operation in satisfactory condition. After pathology report, the patient was referred to a gynecologic oncologist for possible chemotherapy (Figure 2 a-e) .
Discussion
LMS is considered and is known as an aggressive tumor with high mortality and morbidity (1, 5) . There is no reliable diagnostic method to distinguish between uterine LMS and benign uterine tumors before surgery. However, due to increased levels of total lactate dehydrogenase (LDH) and LDH isoenzyme-3 in the patients with LMS, biochemical evaluations are also considered as a useful method. Among imaging studies, a high vascularity score in Doppler ultrasonography and high signal intensity in diffusion weighted imaging (DWI) also indicate malignant ovarian tumors (6) . Diagnosis of LMS and determination of its stage are only based on histopathology report after surgery. Surgical staging of LMS includes hysterectomy, and bilateral salpingo-oophorectomy (BSO). The tumor larger than 5 cm and high mitotic index are important prognostic factors (7) . Hematogenous spread is the most common form, and lymphatic spread is the rare one. Sarcoma is known as an aggressive tumor, meaning that there is still a high risk of local and distant recurrence after the tumor is removed (5) . Stages I and II LMS, according to the International Federation of Gynecology and Obstetrics (FIGO) staging systems, have a very high risk of relapse, while its survival rate is also poor after relapse. One study indicated that the survival rates of LMS I and II are 50% and 25%, respectively (8) . Site of metastasis or recurrence is often around the liver and lungs, which is due to hematogenous spread (9) . The patients with early stage LMS do not really undergo radiation therapy, and there is no overall survival benefit regarding radiation therapy. Some prospective studies have shown the effectiveness of chemotherapy in the treatment of uterine LMS (10) . In our case due to heavy bleeding, we had no time for doing further diagnostic evaluation. Therefore we decided for surgery. Considering the macroscopic and microscopic features, leiomyosarcoma was diagnosed in the patient and after surgery, the patient was referred to a gynecologic oncologist.
Conclusions
Preoperative algorithm (low risk or high risk) should be aimed in order to avoid the occurrence of unexpected LMS diagnosed on the pathologic post-operative examination and selection of surgery. This should be done in the patients with history of myoma or those highly suspicious to LMS. Clinical and biochemical and ultrasonographic findings suspected of LMS and, only in highly suspected cases, a pelvic MRI could be initiated. And the surgery is the only treatment for leiomyosarcoma.
